文献速递冠心病外科

大隐静脉与右胸廓内动脉作为Y型复合移植物的比较:一项随机试验的五年血管造影与临床结果

Saphenous vein versus right internal thoracic artery as a Y-composite graft: Five-year angiographic and clinical results of a randomized trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-06-04

该随机试验比较了基于原位左胸廓内动脉的Y型复合移植物中,大隐静脉与右胸廓内动脉的5年移植物闭塞率和中期临床结局。共219例多支冠状动脉病变患者纳入分析,结果显示大隐静脉复合移植物在5年闭塞率和中期临床结局方面不劣于右胸廓内动脉复合移植物。

要点

  • 5年总移植物闭塞率为3.6%,大隐静脉组3.5% vs 右胸廓内动脉组3.7%(P = .910)。
  • 大隐静脉组第二肢移植物5年闭塞率为4.3%,不劣于右胸廓内动脉组的2.4%(95%CI -1.4%至5.2%,非劣效性P < .001)。
  • 两组5年和8年总体生存率(P = .439)及无主要不良心脑血管事件生存率(P = .354)无统计学显著差异。

核心结论

  • 大隐静脉复合移植物在5年移植物闭塞率和中期临床结局方面不劣于右胸廓内动脉复合移植物。

研究设计与样本

  • 随机试验,纳入224例多支冠状动脉病变患者,随机接受以大隐静脉(大隐静脉组,n=112)或右胸廓内动脉(右胸廓内动脉组,n=112)作为基于原位左胸廓内动脉的Y型复合移植物行非体外循环血运重建,最终219例(大隐静脉组n=109;右胸廓内动脉组n=110)进入分析。
  • 47例患者使用第三肢导管延长移植物肢以实现完全血运重建(大隐静脉组 vs 右胸廓内动脉组,8 vs 39)。
  • 186例患者(84.9%;大隐静脉组=95;右胸廓内动脉组=91)接受了术后5年(61.7 ± 5.2个月)血管造影。
  • 随访完整率为97.7%(214/219),中位随访时间为80.7个月。

主要发现

  • 5年总移植物闭塞率为3.6%(大隐静脉组3.5% vs 右胸廓内动脉组3.7%,P = .910)。
  • 大隐静脉组第二肢导管5年闭塞率为4.3%,在95%双侧置信区间-1.4%至5.2%内不劣于右胸廓内动脉组的2.4%(非劣效性P < .001)。
  • 两组5年和8年总体生存率(P = .439)及无主要不良心脑血管事件生存率(P = .354)无统计学显著差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared the 5-year graft occlusion rates and midterm clinical outcomes of saphenous vein composite grafts with those of right internal thoracic artery composite grafts in patients who were enrolled in the SAphenous VEin versus Right Internal Thoracic Artery as a Y-Composite Graft trial. METHODS: Of 224 eligible patients with multivessel coronary artery disease who were randomized to undergo off-pump revascularization using the saphenous vein (saphenous vein group, n = 112) or right internal thoracic artery (right internal thoracic artery group, n = 112) as Y-composite grafts based on the in situ left internal thoracic artery from September 2008 to October 2011, 219 patients (saphenous vein group, n = 109; right internal thoracic artery group, n = 110) entered the analysis. A third limb conduit to lengthen the graft limb for complete revascularization was used in 47 patients (saphenous vein group vs right internal thoracic artery group, 8 vs 39). Postoperative 5-year (61.7 ± 5.2 months) angiograms were performed in 186 patients (84.9%; saphenous vein group = 95; right internal thoracic artery group = 91). Follow-up was complete in 97.7% (214/219) of patients with a median follow-up of 80.7 months. RESULTS: The overall graft occlusion rate was 3.6% at 5 years (3.5% in the saphenous vein group vs 3.7% in the right internal thoracic artery group, P = .910). The 5-year occlusion rate of the second limb conduits in the saphenous vein group was 4.3% and was noninferior to that of the right internal thoracic artery group (2.4%) within the 95% 2-sided confidence interval of -1.4% to 5.2% (P < .001 for noninferiority). No statistically significant differences were found in the overall survival (P = .439) and the freedom from major adverse cardiac and cerebrovascular event rates (P = .354) at 5 and 8 years between the 2 groups. CONCLUSIONS: The saphenous vein composite grafts were noninferior to the right internal thoracic artery composite grafts in terms of 5-year graft occlusion rates and midterm clinical outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kim MS, Hwang HY, Kim JS, et al. Saphenous vein versus right internal thoracic artery as a Y-composite graft: Five-year angiographic and clinical results of a randomized trial. J Thorac Cardiovasc Surg. 2018. PMID: 30257282. doi:10.1016/j.jtcvs.2018.04.123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。